Sickle cell telemedicine and standard clinical encounters: A comparison of patient satisfaction

K. F. Woods, A. Kutlar, J. A. Johnson, J. L. Waller, R. K. Grigsby, M. E. Stachura, D. W. Rahn

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives: To determine patient satisfaction with telemedicine encounters among adults with sickle cell disease and compare their scores with SCD patients who have standard medical encounters (as controls). Methods: Adults patients were recruited from a list of participants in sickle cell telemedicine clinics and prospectively at the time of clinic encounter. Patients were assigned to telemedicine or standard encounter groups. Demographic and pertinent clinical data were obtained for all subjects, and the Client Satisfaction Questionnaire (CSQ-8) was administered. Patients were also asked for open-ended comments regarding their satisfaction with the service. Their responses were recorded verbatim. Results: Patients with telemedicine (n = 60) and standard encounters (n = 60) were comparable in gender, genotype, education, employment, and mean number of sickle cell disease-related complications. Patients in the telemedicine group were younger (p < 0.005), more likely to have Medicaid insurance (p = 0.009), and more likely be taking hydroxyurea (p = 0.003) than patients in the control encounter group. Mean CSQ scores for the telemedicine group were high (total: 28.82 ± 3.06), and there was no difference for any item between encounter groups (p = 0.389). Patients in the standard encounter group were more likely to provide positive open-ended comments regarding the encounter (95% vs. 70%; p = 0.001). Negative comments were generally in the area of confidentiality. Conclusions: While some patients expressed concern about confidentiality with telemedicine, the benefits of improved access and continuity of care were recognized, and overall satisfaction with telemedicine was high. These findings support the use of telemedicine as an acceptable health care delivery option for rural, underserved populations with sickle cell disease.

Original languageEnglish (US)
Pages (from-to)349-356
Number of pages8
JournalTelemedicine Journal
Volume5
Issue number4
DOIs
StatePublished - Dec 1 1999

Fingerprint

Telemedicine
Patient Satisfaction
Sensitivity Training Groups
Sickle Cell Anemia
Confidentiality
Continuity of Patient Care
Hydroxyurea
Medicaid
Vulnerable Populations
Rural Population
Insurance
Genotype
Demography
Delivery of Health Care
Education
Control Groups

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sickle cell telemedicine and standard clinical encounters : A comparison of patient satisfaction. / Woods, K. F.; Kutlar, A.; Johnson, J. A.; Waller, J. L.; Grigsby, R. K.; Stachura, M. E.; Rahn, D. W.

In: Telemedicine Journal, Vol. 5, No. 4, 01.12.1999, p. 349-356.

Research output: Contribution to journalArticle

@article{73c0e0eb991a4432b10923d646b912bb,
title = "Sickle cell telemedicine and standard clinical encounters: A comparison of patient satisfaction",
abstract = "Objectives: To determine patient satisfaction with telemedicine encounters among adults with sickle cell disease and compare their scores with SCD patients who have standard medical encounters (as controls). Methods: Adults patients were recruited from a list of participants in sickle cell telemedicine clinics and prospectively at the time of clinic encounter. Patients were assigned to telemedicine or standard encounter groups. Demographic and pertinent clinical data were obtained for all subjects, and the Client Satisfaction Questionnaire (CSQ-8) was administered. Patients were also asked for open-ended comments regarding their satisfaction with the service. Their responses were recorded verbatim. Results: Patients with telemedicine (n = 60) and standard encounters (n = 60) were comparable in gender, genotype, education, employment, and mean number of sickle cell disease-related complications. Patients in the telemedicine group were younger (p < 0.005), more likely to have Medicaid insurance (p = 0.009), and more likely be taking hydroxyurea (p = 0.003) than patients in the control encounter group. Mean CSQ scores for the telemedicine group were high (total: 28.82 ± 3.06), and there was no difference for any item between encounter groups (p = 0.389). Patients in the standard encounter group were more likely to provide positive open-ended comments regarding the encounter (95{\%} vs. 70{\%}; p = 0.001). Negative comments were generally in the area of confidentiality. Conclusions: While some patients expressed concern about confidentiality with telemedicine, the benefits of improved access and continuity of care were recognized, and overall satisfaction with telemedicine was high. These findings support the use of telemedicine as an acceptable health care delivery option for rural, underserved populations with sickle cell disease.",
author = "Woods, {K. F.} and A. Kutlar and Johnson, {J. A.} and Waller, {J. L.} and Grigsby, {R. K.} and Stachura, {M. E.} and Rahn, {D. W.}",
year = "1999",
month = "12",
day = "1",
doi = "10.1089/107830299311916",
language = "English (US)",
volume = "5",
pages = "349--356",
journal = "Telemedicine and e-Health",
issn = "1530-5627",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Sickle cell telemedicine and standard clinical encounters

T2 - A comparison of patient satisfaction

AU - Woods, K. F.

AU - Kutlar, A.

AU - Johnson, J. A.

AU - Waller, J. L.

AU - Grigsby, R. K.

AU - Stachura, M. E.

AU - Rahn, D. W.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Objectives: To determine patient satisfaction with telemedicine encounters among adults with sickle cell disease and compare their scores with SCD patients who have standard medical encounters (as controls). Methods: Adults patients were recruited from a list of participants in sickle cell telemedicine clinics and prospectively at the time of clinic encounter. Patients were assigned to telemedicine or standard encounter groups. Demographic and pertinent clinical data were obtained for all subjects, and the Client Satisfaction Questionnaire (CSQ-8) was administered. Patients were also asked for open-ended comments regarding their satisfaction with the service. Their responses were recorded verbatim. Results: Patients with telemedicine (n = 60) and standard encounters (n = 60) were comparable in gender, genotype, education, employment, and mean number of sickle cell disease-related complications. Patients in the telemedicine group were younger (p < 0.005), more likely to have Medicaid insurance (p = 0.009), and more likely be taking hydroxyurea (p = 0.003) than patients in the control encounter group. Mean CSQ scores for the telemedicine group were high (total: 28.82 ± 3.06), and there was no difference for any item between encounter groups (p = 0.389). Patients in the standard encounter group were more likely to provide positive open-ended comments regarding the encounter (95% vs. 70%; p = 0.001). Negative comments were generally in the area of confidentiality. Conclusions: While some patients expressed concern about confidentiality with telemedicine, the benefits of improved access and continuity of care were recognized, and overall satisfaction with telemedicine was high. These findings support the use of telemedicine as an acceptable health care delivery option for rural, underserved populations with sickle cell disease.

AB - Objectives: To determine patient satisfaction with telemedicine encounters among adults with sickle cell disease and compare their scores with SCD patients who have standard medical encounters (as controls). Methods: Adults patients were recruited from a list of participants in sickle cell telemedicine clinics and prospectively at the time of clinic encounter. Patients were assigned to telemedicine or standard encounter groups. Demographic and pertinent clinical data were obtained for all subjects, and the Client Satisfaction Questionnaire (CSQ-8) was administered. Patients were also asked for open-ended comments regarding their satisfaction with the service. Their responses were recorded verbatim. Results: Patients with telemedicine (n = 60) and standard encounters (n = 60) were comparable in gender, genotype, education, employment, and mean number of sickle cell disease-related complications. Patients in the telemedicine group were younger (p < 0.005), more likely to have Medicaid insurance (p = 0.009), and more likely be taking hydroxyurea (p = 0.003) than patients in the control encounter group. Mean CSQ scores for the telemedicine group were high (total: 28.82 ± 3.06), and there was no difference for any item between encounter groups (p = 0.389). Patients in the standard encounter group were more likely to provide positive open-ended comments regarding the encounter (95% vs. 70%; p = 0.001). Negative comments were generally in the area of confidentiality. Conclusions: While some patients expressed concern about confidentiality with telemedicine, the benefits of improved access and continuity of care were recognized, and overall satisfaction with telemedicine was high. These findings support the use of telemedicine as an acceptable health care delivery option for rural, underserved populations with sickle cell disease.

UR - http://www.scopus.com/inward/record.url?scp=0033492502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033492502&partnerID=8YFLogxK

U2 - 10.1089/107830299311916

DO - 10.1089/107830299311916

M3 - Article

C2 - 10908450

AN - SCOPUS:0033492502

VL - 5

SP - 349

EP - 356

JO - Telemedicine and e-Health

JF - Telemedicine and e-Health

SN - 1530-5627

IS - 4

ER -